Cortica Raises $75 Million & Acquires Springtide Child Development & Melmed Center

Autism treatment provider organization Cortica, Inc. closed a $75 million financing round and acquired Springtide Child Development and Melmed Center. The funding round was led by Deerfield Management and Optum Ventures. Additional new investors include RA Capital Management and Echo Health Ventures, alongside existing Cortica investors Longitude Capital, .406 Ventures, Questa Capital, Ajax Health, Aperture Venture Partners, and the Autism Impact Fund.

Both Springtide and Melmed Center provide autism treatment. With these two acquisitions, Cortica owns and operates 23 integrated autism centers across the country. Springtide provides autism treatment services in the Northeastern U.S. Springtide's investors have rolled . . .